Comparison of 18F-Fluorothymidine and 18F-Fluorodeoxyglucose PET/CT in Delineating Gross Tumor Volume by Optimal Threshold in Patients With Squamous Cell Carcinoma of Thoracic Esophagus

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 4, 2010, Pages 1235-1241

  Han, Dali ^a   Yu, Jinming ^a   Yu, Yonghua ^a   Zhang, Guifang ^a   Zhong, Xiaojun ^a   Lu, Jie ^a   Yin, Yong ^a   Fu, Zheng ^a   Mu, Dianbin ^a   Zhang, Baijiang ^a   He, Wei ^a   Huo, Zhijun ^a   Liu, Xijun ^a   Kong, Lei ^a   Zhao, Shuqiang ^a   Sun, Xiangyu ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Esophageal carcinoma; positron emission tomography; radiotherapy

Indexed keywords

COMPUTED TOMOGRAPHY; ESOPHAGEAL CARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; F-FLUORODEOXYGLUCOSE; GROSS TUMOR VOLUME; HEART VOLUMES; LUNG VOLUME; MEAN LUNG DOSE; OPTIMAL METHODS; OPTIMAL THRESHOLD; POTENTIAL BENEFITS; RADIATION DOSE; SPINAL CORDS; SQUAMOUS CELL CARCINOMA; STANDARD DEVIATION; STANDARDIZED UPTAKE VALUES; TREATMENT PLANNING;

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; DOSIMETRY; HEART; OPTIMIZATION; POSITRONS; RADIOTHERAPY; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

3' FLUOROTHYMIDINE F 18; FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HEART VOLUME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG VOLUME; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; SPINAL CORD; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; DIDEOXYNUCLEOSIDES; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; LUNG; LYMPH NODE EXCISION; MALE; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SPINAL CORD; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 77449145236     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.07.1681     Document Type: Article

References (17)

1. Zhang Z., Liao Z., Jin J., et al. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 656-664
2. Hong T.S., Crowley E.M., Killoran J., et al. Considerations in treatment planning for esophageal cancer. Semin Radiat Oncol 17 (2007) 53-61
3. Vesprini D., Ung Y., Dinniwell R., et al. Improving observer variability in target delineation for gastro-oesophageal cancer-The role of (18F)fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography. Clin Oncol (R Coll Radiol) 20 (2008) 631-638
4. Moureau-Zabotto L., Touboul E., Lerouge D., et al. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys 63 (2005) 340-345
5. Arslan N., MillerTR D.F., et al. Evaluation of response to neoadjuvant therapy by quantitative 2-deoxy-2-[18f]fluoro-d-glucose with positron emission tomography in patients with esophageal cancer. Mol Imaging Biol 4 (2002) 301-310
6. Kubota R., Yamada S., Kubota K., et al. Intratumoral distribution of fluorine- 18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33 (1992) 1972-1980
7. Nakamura R., Obara T., Katsuragawa S., et al. Failure in presumption of residual disease by quantification of FDG uptake in esophageal squamous cell carcinoma immediately after radiotherapy. Radiat Med 20 (2002) 181-186
8. Guo H., Zhu H., Yu J., et al. Diagnostic and prognostic value of 18F-FDG PET-CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus. J Nucl Med 48 (2007) 1251-1258
9. Zhong X., Yu J., Zhang B., et al. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 73 (2009) 136-141
10. Tian J., Yang X., Yu L., et al. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3′-deoxy-3′-18F-fluorothymidine and 18F-FDG. J Nucl Med 49 (2008) 186-194
11. Button M.R., Morgan C.A., Croydon E.S., et al. Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 73 (2009) 818-823
12. Gao X.S., Qiao X., Wu F., et al. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys 67 (2007) 389-396
13. Nakamura T., Hatooka S., Kodaira T., et al. Determination of the irradiation field for clinical T1-T3N0M0 thoracic/abdominal esophageal cancer based on the postoperative pathological results. Jpn J Clin Oncol 39 (2009) 86-91
14. Lu J.J., and Brady L.W. Esophageal cancer in radiation oncology (2008), Springer, Verlag p. 182-195
15. Daisne J.F., Duprez T., Weynand B., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233 (2004) 93-100
16. Paulino A.C., Koshy M., Howell R., et al. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1385-1392
17. Ma G.W., Rong T.H., Long H., et al. Shrinkage of resected specimens of esophageal carcinoma. Ai Zheng 23 (2004) 193-195